The dependency is stated, and not priced
Each drug page ends with the same four-line table: the frequency of the injection, whether a lab is required, and the starting price. Lab required, yes. Then the figure.
Publishing a dependency beside a price is a genuine disclosure and it is rare here. Leaving the dependency unpriced means neither figure is what a first month costs, and the page does not say by how much.
Floors, not rates
Both figures are starting-from rates. No dose ladder, no plan term and no membership position appear on either page. What raises the bill above the floor is not disclosed.
It sells a third molecule, retatrutide, alongside the two established ones. That molecule has no FDA-approved finished product of any kind, which is a different situation from a compounded version of an approved drug.
A page nobody else in this market runs
The site publishes a regulatory-updates section. Whatever is in it at a given moment, a seller in this category choosing to keep a page about the rules it operates under is unusual enough to be worth a reader's attention.
No operating company is named. The only corporate-suffix match anywhere on the host is its own navigation label, repeated ten times. No compounding pharmacy, no individual clinician and no service area is published.
OptiMale USA's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $199/mo"Starting from: $199/month", printed in a spec table whose line immediately above reads "Lab required: Yes" — and the lab is not priced anywhere on the page, so this is not an all-in figure | September 2026source |
| Tirzepatide (compounded) | $299/mo"Starting from: $299/month", from the same spec table shape, with the same unpriced lab requirement stated above it | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 198 providers reviewed here are paid partners today; the other 194 are not. See how this works.
See OptiMale USA's current price →Good fit if
- Readers who want to know before starting whether a lab charge is coming.
- Buyers who want each drug priced on its own page with a consistent spec table.
- People interested in a seller that maintains a page about the regulatory position of what it sells.
Look elsewhere if
- Anyone who needs an all-in first-month figure, since the required lab is not priced.
- Readers who want a dose ladder or a plan term behind a starting-from figure.
- Buyers who need to know which company they are contracting with.
- People who want a named pharmacy, a named clinician or a service-area list.
How this review was verified
- Re-read both priced drug pages, the about page and the privacy policy on 7 September 2026, comparing requested to effective URLs and running a nonsense path against the host in the same run, which returned a 404.
- Read the lab-required line as part of the price disclosure and wrote it into the stored qualifier for both rows.
- Recorded both figures as starting-from floors rather than rates.
- Ran a widened corporate-suffix pattern across every cached body on the host, proved first against a page known to name a company; the only match is a navigation label, read in context and rejected.
- Screened the brand against FDA's live warning-letter datatable with a positive control and a nonsense negative control in the same invocation; the screen returned zero matches.